PARTNERSHIPs

Cancer doesn’t wait. Neither should T cells.

PyroTIMER is a universal plug-in that boosts T cell function in suppressive microenvironments.

the problem

Cell therapies fail in solid tumors. Not because of cells — but because of where they're sent.

Immunosuppressive tumor microenvironments (TIME) shut T cells down before they can act.

Persistence drops. Cytotoxicity fades. Exhaustion sets in. And therapies that work in blood cancers often fall flat in solid ones.

PyroTIMER reprograms the TIME.

Engineered to function where others fail.

Engineered cells secrete proprietary fusion peptides that neutralize suppressive signals in the tumor microenvironment (TIME) — restoring T cell function, even in hostile conditions.

Designed to intregrate. Built to outperform.

PyroTIMER integrates directly into CAR-T, TCR-T, and TIL pipelines — boosting efficacy without redesigning the therapeutic backbone.

2-3x

greater tumor control (vs. standard CAR-T)

80%

reduction in T cell exhaustion

2-4x

improved persistence
in vivo

Trusted by partners at the edge of science

Now available for integration.

We're actively licensing PyroTIMER to strategic partners ready to improve efficacy in solid and hematological tumors.

GET IN TOUCH